AlphaCentric Advisors »

Bank of New York Mellon Corporation shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Bank of New York Mellon Corporation (BK) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Bank of New York Mellon Corporation

Tip: Access up to 7 years of quarterly data

All positions including Bank of New York Mellon Corporation held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bank of New York Mellon Corporation by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $105k 1.8k 57.62

More positions owned by AlphaCentric Advisors

Pfizer (PFE)
Rithm Capital Corp Com New (RITM)
Harmony Biosciences Hldgs In (HRMY)
United Therapeutics Corporation (UTHR)
Pacira Pharmaceuticals (PCRX)
BioCryst Pharmaceuticals (BCRX)
Galapagos Nv Spon Adr (GLPG)
Argenx Se Sponsored Adr (ARGX)
Two Harbors Inventment Corpo Note 6.250% 1/1
Inari Medical Ord (NARI)
Docgo (DCGO)
Beigene Sponsored Adr (BGNE)
Ellington Financial Inc ellington financ (EFC)
Axsome Therapeutics (AXSM)
MGIC Investment (MTG)

View all positions for AlphaCentric Advisors

Top funds holding Bank of New York Mellon Corporation

Vanguard Group
BlackRock
Dodge & Cox
Artisan Partners Limited Partnership
First Eagle Investment Management
Norges Bank Investment Management
Davis Selected Advisers
Amundi
Hotchkis and Wiley Capital Management
Harris Associates L.P
Wells Fargo & Company
Victory Capital Management
Legal & General Group
LSV Asset Management
Dimensional Fund Advisors

View all funds holding Bank of New York Mellon Corporation